Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIncreased flatulence is a recognised side effect of Mounjaro (tirzepatide). It happens because the medicine slows the movement of food through your gut, altering how and where bacteria break down what you eat — producing more gas in the process. For most people, farting on Mounjaro is at its worst in the first few weeks and tends to settle as the body adjusts. It is rarely a reason to stop treatment, but it is uncomfortable enough that it is worth understanding what is driving it and what you can do about it. Mounjaro is a prescription-only medicine, so any decision about dosing or managing side effects should involve your prescriber, who will look at your full clinical picture before advising you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the scene: you have eaten a modest dinner, far less than you used to manage, and yet an hour later you feel bloated and uncomfortably gassy. This is one of the most common complaints our prescribers hear from people in the first month on Mounjaro, and it has a clear biological explanation.
Tirzepatide activates two gut-hormone receptors, GIP and GLP-1, which together slow the rate at which food leaves your stomach. That delay (called reduced gastric emptying) is part of how the medicine keeps you feeling full. The downside is that undigested food spends longer in the lower gut, where billions of bacteria set to work fermenting it. Fermentation produces gas. More fermentation means more gas, and more gas means more farting on Mounjaro.
There is also a secondary effect worth knowing about. Because tirzepatide reduces how much you eat, many people instinctively shift toward higher-fibre foods to stay full: more vegetables, pulses, wholegrains. Fibre feeds gut bacteria enthusiastically. Add a sparkling water habit and the effect compounds. The NHS's patient information page for tirzepatide lists flatulence alongside other gastrointestinal effects such as nausea, diarrhoea and constipation, all arising from the same underlying mechanism. None of that makes it less embarrassing, but it does confirm you are not unusual for experiencing it.
Patients often say the volume of gas is manageable but the odour is not what they expected. This tracks with what is known about how gut fermentation changes on Mounjaro. When food sits longer before digestion, bacteria produce a different mix of gases, including more hydrogen sulphide, which is responsible for the distinctly unpleasant smell some people notice in the early weeks.
Fatty foods make this worse. Fat is already harder for the gut to process and, combined with slowed gastric emptying, it provides prime fermentation material. Artificial sweeteners and sugar alcohols (found in many low-calorie products people reach for when reducing intake) are another common culprit: they are poorly absorbed and feed bacteria directly. If your diet has shifted toward protein bars or diet drinks since starting treatment, that change alone could explain a significant part of what you are experiencing.
The reassuring part is that this effect is dose-dependent and time-limited for most people. The window is usually at its worst in the first two to four weeks at any given dose, then eases as the gut adapts. People who find the first weeks on Mounjaro particularly rough with GI side effects often report a real improvement by the time they reach week six or eight, without any change to the medicine itself.
It is worth looking at practical strategies for the early weeks to understand how dietary adjustments can make the adjustment period more manageable.
There is no specific medical treatment for Mounjaro-related flatulence, but several practical steps consistently make a difference.
Eating slowly and chewing thoroughly reduces the amount of air swallowed with food, a modest but real contribution to gas volume. Smaller, more frequent meals are easier for a slowed gut to process than one large plate. Avoiding carbonated drinks is straightforward advice that people often overlook because sparkling water feels virtuous when you are cutting calories; on tirzepatide it is worth switching to still. High-gas foods (onions, cabbage, broccoli, lentils, baked beans) are worth spacing out rather than eliminating, because they carry genuine nutritional value your body needs alongside treatment.
Over-the-counter remedies containing simeticone (available at any pharmacy) can reduce gas bubbles in the gut and some people find them helpful, particularly in the evenings. Charcoal tablets are a popular search, but the evidence for them is limited; they are unlikely to cause harm but equally may not do much. If you are concerned about any symptom or want specific guidance on managing it, a conversation with your prescriber is the right step. There is a useful overview of what the evidence says about Mounjaro and excess gas that goes into more detail on the dietary angle.
One thing that will not help: increasing the dose before your gut is ready. If wind is severe and persistent, mention it when your treatment is reviewed before any titration takes place. Dose increases tend to bring a fresh bout of GI adjustment, and going up too quickly makes that harder. The tirzepatide clinical programme, which involved thousands of adults across the SURMOUNT studies, found that GI side effects were notably more frequent at higher doses and around dose-change points, which is precisely why the escalation schedule is paced.
Ordinary flatulence and bloating after starting or adjusting Mounjaro does not need urgent attention. But some symptoms warrant prompt medical assessment.
Severe, persistent stomach pain (particularly pain that radiates toward the back) is not normal wind and should not be dismissed. The MHRA's Drug Safety Update on GLP-1 medicines specifically highlights acute pancreatitis as a known but infrequent serious effect requiring urgent medical review. Other signs worth acting on quickly include signs of dehydration if diarrhoea or vomiting accompanies the gas, significant and sustained abdominal pain, or pain in the upper right abdomen that could suggest a gallbladder issue.
If you ever notice a reaction you are unsure about, the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk allows patients to report suspected side effects directly. It is an underused resource and genuinely feeds into post-market safety monitoring for newer medicines like tirzepatide.
For most people, though, farting on Mounjaro falls into the uncomfortable-but-manageable category. It often improves before the next prescription review comes around. If it has not, or if you are unsure whether what you are experiencing is typical, a call to your prescriber is the sensible first step, and our guide on restarting Mounjaro is worth reading if a break in treatment means you are navigating these early side effects all over again. For those who have been off treatment for a longer period, there is also specific guidance on restarting Mounjaro after a month away, which covers how the gut readjusts when you return to the medicine. You can read more about the broader Mounjaro treatment journey, or explore what is involved in starting treatment on the treatment page, where our prescribers can assess your individual situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.